ORBIMED ADVISORS LLC Insider Trading Transactions
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in GLAUKOS Corp ($GKOS) and Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and in ACCELERON PHARMA INC ($XLRN) and Director in ProNAi Therapeutics Inc ($DNAI) and 10% Owner in AVEDRO INC ($AVDR) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in SI-BONE, Inc. ($SIBN) and Director in Xtant Medical Holdings, Inc. ($XTNT) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and Director in Otonomy, Inc. ($OTIC) and 10% Owner in Arsanis, Inc. ($ASNS) and 10% Owner in Principia Biopharma Inc. ($PRNB) and Director in Acutus Medical, Inc. ($AFIB) and Director in SYNLOGIC, INC. ($MIRN) and 10% Owner in NeuroPace Inc ($NPCE) and 10% Owner in GRAYBUG VISION, INC. ($GRAY) and 10% Owner in Sientra, Inc. ($SIEN) and 10% Owner in TELA Bio, Inc. ($TELA) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Dimension Therapeutics, Inc. ($DMTX) and 10% Owner in Guardant Health, Inc. ($GH) and 10% Owner in ViewRay, Inc. ($VRAY) and Director in ViewRay, Inc. ($VRAY) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and 10% Owner in Inspire Medical Systems, Inc. ($INSP) and Director in Inspire Medical Systems, Inc. ($INSP) and Director in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and Director in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Intellia Therapeutics, Inc. ($NTLA) and 10% Owner in Alector, Inc. ($ALEC) and Director in Alector, Inc. ($ALEC) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in NextCure, Inc. ($NXTC) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in IMARA Inc. ($IMRA) and Director in Keros Therapeutics, Inc. ($KROS) and Director in Prelude Therapeutics Inc ($PRLD) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in resTORbio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and Director in Edgewise Therapeutics, Inc. ($EWTX) and Director in 89bio, Inc. ($ETNB) and Director in Arcutis Biotherapeutics, Inc. ($ARQT) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Fusion Pharmaceuticals Inc. ($FUSN) and Director in Terns Pharmaceuticals, Inc. ($TERN) and Director in Ikena Oncology, Inc. ($IKNA).
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC
Sentiment: All, ETNB, XLRN, AFIB, ADAP, TORC, AGLE, ARPO, ALEC, ALPN, ARQT, ARMO, BOLD, AVDR, CNST, CRVS, CTIC, DBTX, DMTX, EWTX, FUSN, GKOS, GRAY, GH, IKNA, IMRA, INSP, NTLA, ICPT, KALA, KROS, KNTE, LOGC, LOXO, NPCE, NXTC, ORIC, OTIC, PIRS, PMVP, PRLD, PRVL, PRNB, RLYP, RPTX, RPBIF, RYTM, SCPH, SELB, SIBN, SIEN, SRRA, SBTX, ROKA, SWTX, STDY, SYBX, THOR, TELA, TERN, TCDA, TPTX, VRAY, ASNS, XTNT
Page: < prev 1 2 3 4 5 6 ... 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 16.11 | 30,000 | 483,300 | 30,000 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 16.11 | 30,000 | 483,300 | 30,000 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Grant | A | 0.00 | 292,607 | 0 | 292,607 | 0 to 292.6 K |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Grant | A | 0.00 | 902,885 | 0 | 902,855 | -30 to 902.9 K (-3,009,616.67 %) |
Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Grant | A | 0.00 | 4,822,960 | 0 | 4,822,960 | 0 to 4.8 M |
Aug 19 2020 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 108.54 | 43,543 | 4,726,157 | 0 | 43.5 K to 0 (-100.00 %) |
Aug 19 2020 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 107.49 | 94,900 | 10,200,801 | 43,543 | 138.4 K to 43.5 K (-68.55 %) |
Aug 14 2020 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 109.03 | 20,257 | 2,208,621 | 138,443 | 158.7 K to 138.4 K (-12.76 %) |
Aug 14 2020 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 109.93 | 29,251 | 3,215,562 | 158,500 | 187.8 K to 158.5 K (-15.58 %) |
Aug 14 2020 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 107.45 | 42,679 | 4,585,859 | 187,751 | 230.4 K to 187.8 K (-18.52 %) |
Aug 12 2020 | AFIB | Acutus Medical, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 378,733 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,202,117 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 389,116 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 899,985 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 647,582 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 673,123 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 872,302 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,278,718 | 0 | 1,320,218 | 41.5 K to 1.3 M (+3,081.25 %) |
Aug 12 2020 | AFIB | Acutus Medical, In ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 3,784,240 | 0 | 4,157,740 | 373.5 K to 4.2 M (+1,013.18 %) |
Aug 12 2020 | AFIB | Acutus Medical, In ... | ORBIMED ADVISORS LLC | Director | Buy | P | 18.00 | 41,500 | 747,000 | 41,500 | 0 to 41.5 K |
Aug 12 2020 | AFIB | Acutus Medical, In ... | ORBIMED ADVISORS LLC | Director | Buy | P | 18.00 | 373,500 | 6,723,000 | 373,500 | 0 to 373.5 K |
Aug 11 2020 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 105.78 | 39,877 | 4,218,189 | 230,430 | 270.3 K to 230.4 K (-14.75 %) |
Aug 11 2020 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 105.23 | 47,700 | 5,019,471 | 270,307 | 318 K to 270.3 K (-15.00 %) |
Aug 11 2020 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 106.18 | 28,993 | 3,078,477 | 318,007 | 347 K to 318 K (-8.36 %) |
Jul 02 2020 | FUSN | Fusion Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 11,878,051 | 0 | 0 | |
Jul 02 2020 | FUSN | Fusion Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 17.00 | 192,100 | 3,265,700 | 192,100 | 0 to 192.1 K |
Jul 02 2020 | FUSN | Fusion Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 17.00 | 705,900 | 12,000,300 | 2,930,670 | 2.2 M to 2.9 M (+31.73 %) |
Jul 02 2020 | FUSN | Fusion Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,224,770 | 0 | 2,224,770 | 0 to 2.2 M |
Jun 25 2020 | RPTX | Repare Therapeutic ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,601,325 | 0 | 0 | |
Jun 25 2020 | RPTX | Repare Therapeutic ... | ORBIMED ADVISORS LLC | Director | Buy | P | 20.00 | 99,200 | 1,984,000 | 99,200 | 0 to 99.2 K |
Jun 25 2020 | RPTX | Repare Therapeutic ... | ORBIMED ADVISORS LLC | Director | Buy | P | 20.00 | 675,000 | 13,500,000 | 3,276,325 | 2.6 M to 3.3 M (+25.95 %) |
Jun 25 2020 | RPTX | Repare Therapeutic ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,601,325 | 0 | 2,601,325 | 0 to 2.6 M |
May 26 2020 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 8.65 | 231,200 | 1,999,880 | 231,200 | 0 to 231.2 K |
May 26 2020 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 8.65 | 1,156,083 | 10,000,118 | 4,565,948 | 3.4 M to 4.6 M (+33.90 %) |
May 26 2020 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 8.65 | 231,200 | 1,999,880 | 231,200 | 0 to 231.2 K |
May 26 2020 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 8.65 | 1,156,083 | 10,000,118 | 4,565,948 | 3.4 M to 4.6 M (+33.90 %) |
May 20 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 868,016 | 8,680 | 868,016 | |
May 20 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 1,531,984 | 15,320 | 1,531,984 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 236,111 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 373,356 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,875,000 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 236,111 | 0 | 2,765,717 | 2.5 M to 2.8 M (+9.33 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 373,356 | 0 | 2,529,606 | 2.2 M to 2.5 M (+17.32 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,875,000 | 0 | 2,156,250 | 281.3 K to 2.2 M (+666.67 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 281,250 | 4,500,000 | 281,250 | 0 to 281.3 K |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.53 | 15,086 | 354,974 | 1,906,718 | 1.9 M to 1.9 M (-0.78 %) |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.53 | 47,097 | 1,108,192 | 5,955,674 | 6 M to 6 M (-0.78 %) |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.52 | 5,636 | 132,559 | 1,921,804 | 1.9 M to 1.9 M (-0.29 %) |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.52 | 17,595 | 413,834 | 6,002,771 | 6 M to 6 M (-0.29 %) |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.53 | 15,086 | 354,974 | 1,906,718 | 1.9 M to 1.9 M (-0.78 %) |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.53 | 47,097 | 1,108,192 | 5,955,674 | 6 M to 6 M (-0.78 %) |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.52 | 5,636 | 132,559 | 1,921,804 | 1.9 M to 1.9 M (-0.29 %) |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.52 | 17,595 | 413,834 | 6,002,771 | 6 M to 6 M (-0.29 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 148,922 | 0 | 0 | |
Apr 13 2020 | KROS | Keros Therapeutics ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 744,612 | 0 | 0 | |
Apr 13 2020 | KROS | Keros Therapeutics ... | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 375,200 | 6,003,200 | 1,119,812 | 744.6 K to 1.1 M (+50.39 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 148,922 | 0 | 148,922 | 0 to 148.9 K |
Apr 13 2020 | KROS | Keros Therapeutics ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 744,612 | 0 | 744,612 | 0 to 744.6 K |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.79 | 69,893 | 1,662,754 | 1,927,440 | 2 M to 1.9 M (-3.50 %) |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.79 | 218,208 | 5,191,168 | 6,020,366 | 6.2 M to 6 M (-3.50 %) |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.65 | 20,041 | 473,970 | 1,997,333 | 2 M to 2 M (-0.99 %) |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.65 | 62,573 | 1,479,851 | 6,238,574 | 6.3 M to 6.2 M (-0.99 %) |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.10 | 2,224 | 51,374 | 2,017,374 | 2 M to 2 M (-0.11 %) |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.10 | 6,946 | 160,453 | 6,301,147 | 6.3 M to 6.3 M (-0.11 %) |
Apr 02 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 24.50 | 60,645 | 1,485,803 | 2,019,598 | 2.1 M to 2 M (-2.92 %) |
Apr 02 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 24.50 | 189,355 | 4,639,198 | 6,308,093 | 6.5 M to 6.3 M (-2.91 %) |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 24.66 | 13,684 | 337,447 | 2,080,243 | 2.1 M to 2.1 M (-0.65 %) |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 24.66 | 42,727 | 1,053,648 | 6,497,448 | 6.5 M to 6.5 M (-0.65 %) |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 24.45 | 16,409 | 401,200 | 2,093,927 | 2.1 M to 2.1 M (-0.78 %) |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 24.45 | 51,235 | 1,252,696 | 6,540,175 | 6.6 M to 6.5 M (-0.78 %) |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 26.05 | 3,541 | 92,243 | 2,110,336 | 2.1 M to 2.1 M (-0.17 %) |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 26.05 | 11,057 | 288,035 | 6,591,410 | 6.6 M to 6.6 M (-0.17 %) |
Mar 16 2020 | IMRA | IMARA Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 10,046,294 | 0 | 0 | |
Mar 16 2020 | IMRA | IMARA Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,594,902 | 0 | 2,532,402 | 937.5 K to 2.5 M (+170.12 %) |
Mar 16 2020 | IMRA | IMARA Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 937,500 | 15,000,000 | 937,500 | 0 to 937.5 K |
Mar 10 2020 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 83.52 | 500,000 | 41,760,000 | 347,000 | 847 K to 347 K (-59.03 %) |
Mar 05 2020 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 84.42 | 400,000 | 33,768,000 | 847,000 | 1.2 M to 847 K (-32.08 %) |
Mar 05 2020 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 84.55 | 25,000 | 2,113,750 | 1,247,000 | 1.3 M to 1.2 M (-1.97 %) |
Mar 05 2020 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 83.21 | 75,000 | 6,240,750 | 1,272,000 | 1.3 M to 1.3 M (-5.57 %) |
Mar 04 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 26.00 | 38,808 | 1,009,008 | 0 | 38.8 K to 0 (-100.00 %) |
Mar 04 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 26.00 | 445,086 | 11,572,236 | 2,113,877 | 2.6 M to 2.1 M (-17.39 %) |
Mar 04 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 26.00 | 1,390,309 | 36,148,034 | 6,602,467 | 8 M to 6.6 M (-17.39 %) |
Feb 07 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | J | 0.00 | 70,423 | 0 | 91,256 | 20.8 K to 91.3 K (+338.04 %) |
Feb 07 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | J | 0.00 | 70,423 | 0 | 91,256 | 20.8 K to 91.3 K (+338.04 %) |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 429,786 | 0 | 0 | |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 859,573 | 0 | 0 | |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,825,603 | 0 | 0 | |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 429,786 | 0 | 606,286 | 176.5 K to 606.3 K (+243.50 %) |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 859,573 | 0 | 4,067,564 | 3.2 M to 4.1 M (+26.79 %) |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,825,603 | 0 | 3,207,991 | 382.4 K to 3.2 M (+738.94 %) |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | P | 17.00 | 176,500 | 3,000,500 | 176,500 | 0 to 176.5 K |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | P | 17.00 | 382,388 | 6,500,596 | 382,388 | 0 to 382.4 K |
Jan 31 2020 | SRRA | Sierra Oncology, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 19,500 | 0 | 0 | |
Jan 31 2020 | SRRA | Sierra Oncology, I ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,477,320 | 0 | 1,477,320 | 0 to 1.5 M |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.50 | 1,392 | 27,144 | 38,808 | 40.2 K to 38.8 K (-3.46 %) |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.50 | 91,818 | 1,790,451 | 2,558,963 | 2.7 M to 2.6 M (-3.46 %) |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.50 | 286,787 | 5,592,347 | 7,992,776 | 8.3 M to 8 M (-3.46 %) |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.50 | 1,392 | 27,144 | 38,808 | 40.2 K to 38.8 K (-3.46 %) |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.50 | 91,818 | 1,790,451 | 2,558,963 | 2.7 M to 2.6 M (-3.46 %) |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.50 | 286,787 | 5,592,347 | 7,992,776 | 8.3 M to 8 M (-3.46 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 18.60 | 1,200 | 22,320 | 40,200 | 41.4 K to 40.2 K (-2.90 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 18.60 | 2,325 | 43,245 | 2,650,781 | 2.7 M to 2.7 M (-0.09 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 18.60 | 7,275 | 135,315 | 8,279,563 | 8.3 M to 8.3 M (-0.09 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.59 | 8,000 | 156,720 | 41,400 | 49.4 K to 41.4 K (-16.19 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.59 | 15,476 | 303,175 | 2,653,106 | 2.7 M to 2.7 M (-0.58 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.59 | 48,324 | 946,667 | 8,286,838 | 8.3 M to 8.3 M (-0.58 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.82 | 10,400 | 206,128 | 49,400 | 59.8 K to 49.4 K (-17.39 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.82 | 20,350 | 403,337 | 2,668,582 | 2.7 M to 2.7 M (-0.76 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.82 | 63,535 | 1,259,264 | 8,335,162 | 8.4 M to 8.3 M (-0.76 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.66 | 37,900 | 745,114 | 59,800 | 97.7 K to 59.8 K (-38.79 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.66 | 73,879 | 1,452,461 | 2,688,932 | 2.8 M to 2.7 M (-2.67 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.66 | 230,721 | 4,535,975 | 8,398,697 | 8.6 M to 8.4 M (-2.67 %) |
Dec 19 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 18.52 | 105,500 | 1,953,860 | 97,700 | 203.2 K to 97.7 K (-51.92 %) |
Dec 19 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 18.52 | 205,793 | 3,811,286 | 2,762,811 | 3 M to 2.8 M (-6.93 %) |
Dec 19 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 18.52 | 642,807 | 11,904,786 | 8,629,418 | 9.3 M to 8.6 M (-6.93 %) |
Dec 12 2019 | TCDA | Tricida, Inc. | ORBIMED ADVISORS LLC | Director | Sell | S | 40.00 | 1,500,000 | 60,000,000 | 9,614,280 | 11.1 M to 9.6 M (-13.50 %) |
Nov 29 2019 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 72.13 | 2,306 | 166,332 | 1,348,326 | 1.4 M to 1.3 M (-0.17 %) |
Nov 29 2019 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 71.67 | 47,981 | 3,438,798 | 1,350,632 | 1.4 M to 1.4 M (-3.43 %) |
Nov 29 2019 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 70.60 | 3,100 | 218,860 | 1,398,613 | 1.4 M to 1.4 M (-0.22 %) |
Nov 29 2019 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 70.16 | 50,478 | 3,541,536 | 1,401,713 | 1.5 M to 1.4 M (-3.48 %) |
Nov 29 2019 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 69.55 | 20,135 | 1,400,389 | 1,452,191 | 1.5 M to 1.5 M (-1.37 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 28.65 | 758,623 | 21,734,549 | 758,623 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 28.65 | 758,623 | 21,734,549 | 758,623 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 1.16 | 758,623 | 880,003 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 1.16 | 758,623 | 880,003 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 24,142,419 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 24,142,419 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 11,878,249 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 11,878,249 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 977,820 | 0 | 3,027,542 | 2 M to 3 M (+47.71 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 977,820 | 0 | 3,027,542 | 2 M to 3 M (+47.71 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 481,095 | 0 | 2,049,722 | 1.6 M to 2 M (+30.67 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 481,095 | 0 | 2,049,722 | 1.6 M to 2 M (+30.67 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 13.00 | 384,615 | 4,999,995 | 1,568,627 | 1.2 M to 1.6 M (+32.48 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 13.00 | 384,615 | 4,999,995 | 1,568,627 | 1.2 M to 1.6 M (+32.48 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
Oct 31 2019 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | J | 0.00 | 20,833 | 0 | 20,833 | 0 to 20.8 K |
Oct 31 2019 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | J | 0.00 | 20,833 | 0 | 20,833 | 0 to 20.8 K |
Sep 19 2019 | SWTX | SpringWorks Therap ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 1,053,204 | 0 | 0 |